[Sirtuins--modulation of their activity as a novel therapeutic target].

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
Read More Add to Saved list
  • Author(s): Kucińska M;Kucińska M; Piotrowska H; Murias M
  • Source:
    Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego [Pol Merkur Lekarski] 2010 Mar; Vol. 28 (165), pp. 231-5.
  • Publication Type:
    English Abstract; Journal Article; Review
  • Language:
    Polish
  • Additional Information
    • Transliterated Title:
      Sirtuiny--modulacja aktywności jako nowy cel terapeutyczny.
    • Source:
      Publisher: Aluna Publishing Country of Publication: Poland NLM ID: 9705469 Publication Model: Print Cited Medium: Print ISSN: 1426-9686 (Print) Linking ISSN: 14269686 NLM ISO Abbreviation: Pol Merkur Lekarski Subsets: MEDLINE
    • Publication Information:
      Publication: 2023- : Konstancin-Jeziorna, Poland : Aluna Publishing
      Original Publication: Warszawa : MEDPRESS, [1996-
    • Subject Terms:
      Aging/*metabolism ; Longevity/*physiology ; Sirtuins/*drug effects ; Sirtuins/*metabolism; Aged ; Animals ; Apoptosis ; Humans ; Longevity/drug effects ; Neoplasms/drug therapy ; Neoplasms/metabolism ; Neovascularization, Physiologic/physiology ; Neuroprotective Agents/metabolism ; Neuroprotective Agents/pharmacology ; Parkinson Disease/metabolism ; Sirtuin 1/metabolism
    • Abstract:
      Sirtuins are a NAD(+)-dependent deacetylases involved in several cellular processes like e.g. transcriptional silencing, regulation of apoptosis, fat homeostasis and aging. Mammalian sirtuins are located in cytoplasm, nucleus as well as mitochondria. The sirtuins exhibit a number of intriguing biological properties and increase of their activity was correlated with several important physiological functions including regulation of glucose level, impact on angiogenesis and neuroprotection. On the other hand, results of research carried out on the sirtuins activity suggest that their overexpression could be related to Parkinson's disease, or some kind of cancer, however it was also shown that sirtuin inhibitors could be useful for the treatment of cancers by inhibition the formation of tumours and induction of apoptosis. Life span-prolonging effects have also been observed in yeast cells, nematodes and flies upon the overexpression of Sirtuin-1. Although sirtuins appeared as a Janus-faced enzymes selective modulators of their activity could be helpful in treatment of several age-related diseases.
    • Accession Number:
      0 (Neuroprotective Agents)
      EC 3.5.1.- (Sirtuin 1)
      EC 3.5.1.- (Sirtuins)
    • Publication Date:
      Date Created: 20100907 Date Completed: 20101105 Latest Revision: 20100906
    • Publication Date:
      20231215
    • Accession Number:
      20815175